• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Evolus, Inc. - Common Stock (NQ:EOLS)

7.100 -0.470 (-6.21%)
Delayed Quote Updated: 4:00 PM EDT, Oct 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 761,680
Open 7.610
Bid (Size) 6.570 (100)
Ask (Size) 7.250 (1,000)
Prev. Close 7.570
Today's Range 7.015 - 7.610
52wk Range 3.860 - 9.310
Shares Outstanding 54,576,156
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Evolus Expands Innovation Pipeline with Novel Injectable Hair Restoration Program
October 14, 2026
From Evolus, Inc.
Via Business Wire
News headline image
EOLS Investors with $100,000 in Losses Have Opportunity to Join Evolus, Inc. Fraud Investigation with SBS Law
October 12, 2026
From Schall, Brown & Schwartz LLP
Via Business Wire

Performance

52-Week Range 23.7% below 52-week high
7.100
3.8652W Low 9.3152W High
1 Week 9.3% below 1-week high
7.011W Low 7.831W High

Evolus, Inc. - Common Stock (EOLS) traded between $3.86 and $9.31 over the past 52 weeks and last traded at $7.10, 23.7% below its 52-week high. Over the past week it ranged between $7.01 and $7.83.

Past 12 Months
-8.4%
-11.1%
+23.9%
+51.4%
+5.7%
+12.7%
1W -$0.65
1M -$0.89
3M +$1.37
6M +$2.41
YTD +$0.38
1Y +$0.80

EOLS was +12.7% over the past year, +51.4% over six months, +5.7% year to date, -8.4% in the last week.

12 Months vs Market
EOLS
+12.7%
DIA
+13.0%
SPY
+15.5%
QQQ
+18.3%
IWM
+10.4%

Over the past 12 months EOLS returned +12.7% versus DIA (Dow) +13.0%, SPY (S&P 500) +15.5%, QQQ (Nasdaq 100) +18.3% and IWM (Russell 2000) +10.4%.

Volume & Liquidity 0.86× 3-mo avg
Today 761,680 3-mo avg 885.7K
1W
865.5K
1M
764.4K
3M
885.7K
6M
875.0K
YTD
1.0M
1Y
1.1M

EOLS most recently traded 761,680 shares against a 3-month average daily volume of 885.7K.

More News

Read More
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Evolus, Inc. - EOLS
October 06, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
Evolus Launches Wings by Evolus, a New Charitable Platform to Mobilize Its Community in Support of Important Causes
October 01, 2026
From Evolus
Via Business Wire
Evolus Inc (NASDAQ:EOLS) Passes Minervini Trend Template and High Growth Momentum Screen ↗
October 01, 2026
Via Chartmill
Evolus (NASDAQ:EOLS) Tops Q2 EPS Estimates and Raises Revenue Guidance, Shares Gain 5.7% ↗
August 05, 2026
Via Chartmill
News headline image
Telix Appoints David Gill as Chair
August 31, 2026
From Telix Pharmaceuticals Limited
Via GlobeNewswire
News headline image
Evolus Q2 Earnings Call Highlights ↗
August 05, 2026
Via MarketBeat
Topics Earnings
News headline image
Evolus Reports Strong Second Quarter 2026 Financial Results; Delivers Third Consecutive Quarter of Positive Adjusted EBITDA and Raises Full-Year 2026 Financial Outlook
August 05, 2026
From Evolus
Via Business Wire
News headline image
Evolus Expands Strategic Partnership with Symatese to Commercialize Estyme® in Canada, Australia, and New Zealand
August 04, 2026
From Evolus
Via Business Wire
Evolus Inc (NASDAQ:EOLS) Q1 2026 Earnings: Narrowed Loss and Positive EBITDA Drive After-Hours Rally ↗
May 04, 2026
Via Chartmill
News headline image
Evolus to Report Second Quarter Financial Results on August 5, 2026
July 22, 2026
From Evolus
Via Business Wire
News headline image
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 10, 2026
From Evolus
Via Business Wire
News headline image
Evolus Announces Partnership with IBSA to Develop and Commercialize Market-Leading Profhilo® in the United States, Expanding Its Injectable Portfolio into Skin Quality
July 08, 2026
From Evolus
Via Business Wire
News headline image
Evolus to Participate in The Jefferies Global Healthcare Conference
May 19, 2026
From Evolus
Via Business Wire
News headline image
Evolus Announces Commercial Launch of Estyme® Injectable Hyaluronic Acid Gels in Europe
May 11, 2026
From Evolus
Via Business Wire
News headline image
Evolus (EOLS) Q1 2026 Earnings Transcript ↗
May 04, 2026
Via The Motley Fool
Topics World Trade
News headline image
Evolus (EOLS) Q2 2025 Earnings Call Transcript ↗
May 04, 2026
Via The Motley Fool
Topics Earnings World Trade
News headline image
Evolus Reports First Quarter 2026 Financial Results; Company Delivers Second Consecutive Quarter of Positive Adjusted EBITDA and Reaffirms Full-Year Outlook
May 04, 2026
From Evolus
Via Business Wire
News headline image
Evolus to Report First Quarter Financial Results on May 4, 2026
April 14, 2026
From Evolus
Via Business Wire
News headline image
Telix Appoints David Gill as Non-Executive Director
April 01, 2026
From Telix Pharmaceuticals Limited
Via GlobeNewswire
News headline image
Evolus to Participate in the Needham 25th Annual Virtual Healthcare Conference
March 31, 2026
From Evolus
Via Business Wire
News headline image
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 20, 2026
From Evolus
Via Business Wire
News headline image
Why Evolus Stock Soared Today ↗
March 04, 2026
Via The Motley Fool
What's going on in today's session ↗
March 04, 2026
Via Chartmill

Frequently Asked Questions

Is Evolus, Inc. - Common Stock publicly traded?
Yes, Evolus, Inc. - Common Stock is publicly traded.
What exchange does Evolus, Inc. - Common Stock trade on?
Evolus, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Evolus, Inc. - Common Stock?
The ticker symbol for Evolus, Inc. - Common Stock is EOLS on the Nasdaq Stock Market
What is the current price of Evolus, Inc. - Common Stock?
The current price of Evolus, Inc. - Common Stock is 7.100
When was Evolus, Inc. - Common Stock last traded?
The last trade of Evolus, Inc. - Common Stock was at 10/16/26 04:00 PM ET
What is the market capitalization of Evolus, Inc. - Common Stock?
The market capitalization of Evolus, Inc. - Common Stock is 387.49M
How many shares of Evolus, Inc. - Common Stock are outstanding?
Evolus, Inc. - Common Stock has 387M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap